These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37494059)

  • 21. Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors.
    Martin JA; Warner RRP; Aronson A; Wisnivesky JP; Kim MK
    Pancreas; 2017 Oct; 46(9):1214-1218. PubMed ID: 28902794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Nomogram Based on the Log Odds of Positive Lymph Nodes Predicts the Prognosis of Patients with Colon Neuroendocrine Tumors After Surgery: A Surveillance, Epidemiology, and End Results Population-Based Study.
    Zhang X; Zhang K; Li S; Xu A
    Technol Cancer Res Treat; 2023; 22():15330338231180776. PubMed ID: 37345370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
    Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
    Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Nomograms Based on Three Lymph Node Classification Systems for Resected Gastric Adenocarcinoma: A Large Population-Based Cohort Study and External Validation.
    Che K; Wang Y; Wu N; Liu Q; Yang J; Liu B; Wei J
    Ann Surg Oncol; 2021 Dec; 28(13):8937-8949. PubMed ID: 34241748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany.
    Grundmann N; Voigtländer S; Hakimhashemi A; Pape UF; Meyer M; Müller-Nordhorn J
    Cancer Med; 2023 Oct; 12(19):19949-19958. PubMed ID: 37737059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms.
    Pommergaard HC; Nielsen K; Sorbye H; Federspiel B; Tabaksblat EM; Vestermark LW; Janson ET; Hansen CP; Ladekarl M; Garresori H; Hjortland GO; Sundlöv A; Galleberg R; Knigge P; Kjaer A; Langer SW; Knigge U
    J Neuroendocrinol; 2021 May; 33(5):e12967. PubMed ID: 33769624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
    Broadbent R; Wheatley R; Stajer S; Jacobs T; Lamarca A; Hubner RA; Valle JW; Amir E; McNamara MG
    Cancer Treat Rev; 2021 Dec; 101():102299. PubMed ID: 34662810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel prognostic model based on log odds of positive lymph nodes to predict outcomes of patients with anaplastic thyroid carcinoma after surgery.
    Tang J; Tian Y; Xi X; Ma J; Li H; Wang L; Zhang B
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):822-832. PubMed ID: 35355304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
    Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
    [No Abstract]   [Full Text] [Related]  

  • 32. Expression of O(6)-methylguanine DNA methyltransferase (MGMT) and its clinical significance in gastroenteropancreatic neuroendocrine neoplasm.
    Yang QC; Wang YH; Lin Y; Xue L; Chen YJ; Chen MH; Chen J
    Int J Clin Exp Pathol; 2014; 7(7):4204-12. PubMed ID: 25120800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.
    Occhionorelli S; Andreotti D; Vallese P; Morganti L; Lacavalla D; Forini E; Pascale G
    World J Surg Oncol; 2018 Sep; 16(1):186. PubMed ID: 30213260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.
    Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J
    Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validated Risk-Score Model Predicting Lymph Node Metastases in Patients with Non-Functional Gastroenteropancreatic Neuroendocrine Tumors.
    Shannon AB; Straker RJ; Fraker DL; Miura JT; Karakousis GC
    J Am Coll Surg; 2022 May; 234(5):900-909. PubMed ID: 35426404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    Masui T; Ito T; Komoto I; Uemoto S;
    BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis.
    Jin S; Wang J; Shen Y; Gan H; Xu P; Wei Y; Wei J; Wu J; Wang B; Wang J; Yang C; Zhu Y; Ye D
    Int Urol Nephrol; 2020 Jan; 52(1):87-95. PubMed ID: 31552575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis.
    Krieg S; Roderburg C; Fung S; Luedde T; Knoefel WT; Krieg A
    J Cancer Res Clin Oncol; 2022 Sep; 148(9):2235-2246. PubMed ID: 35428913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan.
    Yamamoto S; Sakakibara N; Hirano H; Morizane C; Honma Y; Hijioka S; Okusaka T; Higashi T; Kawai A
    Sci Rep; 2022 Oct; 12(1):17601. PubMed ID: 36266484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Discrimination of Alternative Lymph Node Classification Systems for Patients with Radically Resected Non-Metastatic Colorectal Cancer: A Cohort Study from a Single Tertiary Referral Center.
    Prassas D; Verde PE; Pavljak C; Rehders A; Krieg S; Luedde T; Knoefel WT; Krieg A
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.